Publications (29) MARÍA JOSÉ SERRANO FERNÁNDEZ publications

filter_list Cancer Research

2025

  1. Evaluating MicroRNAs as diagnostic tools for lymph node metastasis in breast cancer: Findings from a systematic review and meta-analysis

    Critical Reviews in Oncology/Hematology, Vol. 207

  2. Resectable Non-Small Cell Lung Cancer Heterogeneity and Recurrence Assessed by Tissue Next-Generation Sequencing Genotyping and Circulating Tumor Cell EZH2 Characterization

    Archivos de Bronconeumologia, Vol. 61, Núm. 3, pp. 156-165

2023

  1. Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer

    Cancer, Vol. 129, Núm. 4, pp. 521-530

  2. Circulating tumor cells in cancer-risk populations as a cancer interception tool

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 113-129

  3. microRNAs signature in relapse metastasis and de novo metastasis of breast cancer. A systematic review

    Critical Reviews in Oncology/Hematology, Vol. 188

2022

  1. Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior

    Theranostics, Vol. 12, Núm. 5, pp. 2150-2161

  2. Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1

2021

  1. Circulating tumor cells enumeration from the portal vein for risk stratification in early pancreatic cancer patients

    Cancers, Vol. 13, Núm. 24

  2. Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective

    Journal of Molecular Pathology, Vol. 2, Núm. 3, pp. 255-273

2020

  1. Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients

    Scientific Reports, Vol. 10, Núm. 1

  2. The polemic diagnostic role of TP53 mutations in liquid biopsies from breast, colon and lung cancers

    Cancers, Vol. 12, Núm. 11, pp. 1-17

2019

  1. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents

    Cells, Vol. 8, Núm. 11

  2. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy

    Breast Cancer Research, Vol. 21, Núm. 1

  3. Liquid biopsy beyond of cancer: Circulating pulmonary cells as biomarkers of COPD aggressivity

    Critical Reviews in Oncology/Hematology, Vol. 136, pp. 31-36

  4. Post-surgery circulating tumor cells and AXL overexpression as new poor prognostic biomarkers in resected lung adenocarcinoma

    Cancers, Vol. 11, Núm. 11

2018

  1. Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients

    Journal of Translational Medicine, Vol. 16, Núm. 1

2017

  1. Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers

    European Journal of Cardio-thoracic Surgery, Vol. 52, Núm. 1, pp. 55-62

  2. Exosomes as diagnostic and predictive biomarkers in lung cancer

    Journal of Thoracic Disease, Vol. 9, pp. S1373-S1382

  3. Significance of EGFR expression in circulating tumor cells

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 285-296

2016

  1. Dormant circulating tumor cells in prostate cancer: Therapeutic, clinical and biological implications

    Current Drug Targets, Vol. 17, Núm. 6, pp. 693-701